About Vivo Biosciences
Vivo Biosciences is a Healthcare company based in Birmingham (United States) founded in 2004, and was acquired by LifeNet Health in November 2016. Life science research products and preclinical services are provided. Vivo Biosciences has raised $2 million across 9 funding rounds from investors including HHS, LifeNet Health and NIH SBIR/STTR. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
Vivo Biosciences products and services for life science research. Products include biogel, assay kits, assay plates, cell cultures and culture lines. It offers preclinical drug reserach services for drug eficacy testing, tumorigenesis assays, real-time imaging, functional gene profiling analysis using HuBiogel platform technology. It also offers morphoscan which is live cell imaging analysis system.
- Headquarters Birmingham, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website vivobiotech.com
- Acquired by LifeNet Health (Nov 2016)
- Total Equity Funding$2M (USD)
in 9 rounds
- Latest Funding Round$156.98K (USD), Grant
Aug 2014
- InvestorsHHS
& 2 more
- Acquired byLifeNet Health
(Nov 2016)
Funding Insights of Vivo Biosciences
Vivo Biosciences has successfully raised a total of $2M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $156.98 thousand completed in August 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2M
- Total Rounds 9
- Last Round Grant — $156,981
- First Round $171,654
(Jun 2009)
- Investors Count 2
All 9 funding rounds of Vivo Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Vivo Biosciences
Vivo Biosciences has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, LifeNet Health and NIH SBIR/STTR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| sbir.nih.gov | ||||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Allograft bio-implants are supplied for surgical and regenerative medicine uses. | 1982 | lifenethealth.org | Virginia Beach, United States |
Investor details for Vivo Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Vivo Biosciences
4 dated milestones of Vivo Biosciences across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Vivo Biosciences is founded.
- Funding First funding round of $172K.
- Funding Latest funding round, Grant, of $157K.
- Exit Acquired by LifeNet Health.
Competitors of Vivo Biosciences
Vivo Biosciences has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of Vivo Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Vivo Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Vivo Biosciences
Vivo Biosciences was founded in 2004 and raised its 1st funding round 5 years after it was founded.
Vivo Biosciences is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.
Vivo Biosciences is a funded company, having raised a total of $2M across 9 funding rounds to date. The company's 1st funding round was a Grant of $171.65K, raised on Jun 2009.
Vivo Biosciences products and services for life science research. Products include biogel, assay kits, assay plates, cell cultures and culture lines. It offers preclinical drug reserach services for drug eficacy testing, tumorigenesis assays, real-time imaging, functional gene profiling analysis using HuBiogel platform technology. It also offers morphoscan which is live cell imaging analysis system.
Vivo Biosciences's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Vivo Biosciences has 3 investors. Key investors include HHS, LifeNet Health, and NIH SBIR/STTR.
Yes. Vivo Biosciences was acquired by LifeNet Health in November 2016.